单次应用4%氯己定清洁脐带预防乌干达新生儿感染的效果:随机对照试验研究方案
该研究为在乌干达卫生机构内开展的个体随机对照试验,纳入4760名新生儿,比较出生时单次应用4%氯己定清洁脐带与干脐带护理对脐炎和新生儿重症疾病风险的影响,主要结局为新生儿期重症疾病和脐炎,分析按意向性治疗进行。
要点
- 患脐炎新生儿全因死亡 odds 比无脐炎者高46%。
- 亚洲和撒哈拉以南非洲的五项大型随机对照试验显示多次应用4%氯己定降低脐炎风险,但单次应用仅在孟加拉国研究过。
核心结论
- 该研究将为撒哈拉以南非洲地区提供出生时单次应用4%氯己定清洁脐带效果的新证据,并识别脐炎的可改变危险因素。
研究设计与样本
- CHX研究为在乌干达卫生机构内开展的个体随机对照试验,将在4760名新生儿中进行。
- 主要结局为新生儿期重症疾病和脐炎,分析按意向性治疗进行。
主要发现
- 患脐炎新生儿全因死亡 odds 比无脐炎者高46%。
- 亚洲和撒哈拉以南非洲的五项大型随机对照试验(均为社区为基础)显示,多次应用4%氯己定至少7天降低脐炎风险。
- 仅有一项南亚(孟加拉国)研究及无非洲研究探讨了出生后尽快单次应用4%氯己定的效果;该孟加拉国试验中氯己定降低了轻中度脐炎和新生儿死亡风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Yearly, nearly all the estimated worldwide 2.7 million neonatal deaths occur in low- and middle-income countries. Infections, including those affecting the umbilical cord (omphalitis), are a significant factor in approximately a third of these deaths. In fact, the odds of all-cause mortality are 46% higher among neonates with omphalitis than in those without. Five large randomized controlled trials in Asia and Sub-Saharan Africa (SSA) have examined the effect of multiple cord stump applications with 4% chlorhexidine (CHX) for at least 7 days on the risk of omphalitis and neonatal death. These studies, all community-based, show that multiple CHX applications reduced the risk of omphalitis. Of these trials, only one study from South Asia (the Bangladeshi study) and none from Africa examined the effect of a single application of CHX as soon as possible after birth. In this Bangladeshi trial, CHX led to a reduction in the risk of mild-moderate omphalitis and neonatal death. It is important, in an African setting, to explore the effect of a single application among health-facility births. A single application is programmatically much simpler to implement than daily applications for 7 days. Therefore, our study compares umbilical cord cleansing with a single application of 4% CHX at birth with dry cord care among Ugandan babies born in health facilities, on the risk of omphalitis and severe neonatal illness. METHODS: The CHX study is a facility-based, individually randomized controlled trial that will be conducted among 4760 newborns in Uganda. The primary outcomes are severe illness and omphalitis during the neonatal period. Analysis will be by intention-to-treat. DISCUSSION: This study will provide novel evidence, from a Sub-Saharan African setting, of the effect of umbilical cord cleansing with a single application of 4% CHX at birth and identify modifiable risk factors for omphalitis. TRIAL REGISTRATION: ClinicalTrials.gov, identifier: NCT02606565 . Registered on 12 November 2015.
引用
- Nankabirwa V, Tylleskär T, Tumuhamye J, et al. Efficacy of umbilical cord cleansing with a single application of 4% chlorhexidine for the prevention of newborn infections in Uganda: study protocol for a randomized controlled trial. Trials. 2017. PMID: 28701228. doi:10.1186/s13063-017-2050-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。